What we do Accent Microcell Ltd manufactures high-quality microcrystalline cellulose excipients used in pharmaceutical, nutraceutical, food, and cosmetic industries. |
Founded in 2,012 |
Market share Leading manufacturer in India's microcrystalline cellulose market with global sales in 70+ countries. |
Problem solved Provides essential cellulose-based excipients that enhance drug formulation stability, nutrition products, and cosmetics. |
Top clients or who we serve Serves global pharmaceutical, nutraceutical, food, and cosmetic companies; B2B model. |
Key management Chairman: Vasant Vadilal Patel; Managing Director: Ghanshyam Arjanbhai Patel; Whole-time Directors: Nitin Jasvantbhai Patel, Vinodbhai Manibhai Patel. |
Our journey and innovations Founded from a 2002 partnership, established two modern plants, launched new excipient products, IPO in 2023, expanding facility commissioning in 2025. |
Where we operate India (Gujarat) manufacturing units; exports across Asia, Australia, Americas, Europe, Middle East. |
Top products or what we offer Microcrystalline cellulose variants including Spray Dried MCC, SMCC, MCC with CMC; specialty excipients for pharma and nutrition. |
Top brands Accel 591, Accel 581, Accel S, Maccel, Acrocell, RC products - innovative excipient lines. |
Raw materials needed Cellulose raw materials sourced for excipient production. |
Raw materials supplier Details not specified; suppliers aligned with pharmaceutical excipient industry standards. |
Recurring vs cyclical contribution Revenue predominantly recurring from ongoing supply contracts to pharma and food sectors. |
Our industry position Strong domestic presence with growing export footprint; respected for quality and innovation in excipients. |
Financial highlights FY 2024-25 revenue Rs 264.58 crore; net profit Rs 33.06 crore; profit growth around 9.6%. |
Geographical revenue split Export sales Rs 141.53 crore; Domestic sales Rs 131.19 crore in FY 2024-25. |
Order book - |
Whats driving growth Product innovation, expanding global demand for excipients, increased production capacity, and new facility development. |
Our future plans New manufacturing facility in Navagam Kheda, Gujarat targeted for commercialization by March 2025. |
Our green promise Committed to energy conservation, waste management, and safe workplace policies. |
Our people and values Focus on employee safety, inclusive culture, and compliance with governance standards. |
Key challenges ahead Raw material price stability, regulatory compliance, competition from global excipient makers. |
Interesting facts Exports to over 70 countries; successful IPO in 2023 raising Rs 78.4 crore. |
Risks and strategy Mitigates supply chain and regulatory risks via robust quality and risk management systems. |
